Aktis Oncology, Inc. (AKTS)
Nasdaq: AKTS · CIK 0002035832 · United States
Every official Aktis Oncology, Inc. filing in one place: annual reports, quarterly results, current reports,
proxy statements, shareholding and announcements, straight from the regulator. Free to search.
Open AKTS filings
Aktis Oncology, Inc. documents
- Aktis Oncology, Inc. 10-K 2026AKTS 10-K 2026: annual report for fiscal 2026
- Aktis Oncology, Inc. 10-K 2025AKTS 10-K 2025: annual report for fiscal 2025
- Aktis Oncology, Inc. 10-K 2024AKTS 10-K 2024: annual report for fiscal 2024
- Aktis Oncology, Inc. 10-K 2023AKTS 10-K 2023: annual report for fiscal 2023
- Aktis Oncology, Inc. 10-K 2022AKTS 10-K 2022: annual report for fiscal 2022
- Aktis Oncology, Inc. 10-Q 2026AKTS 10-Q 2026: quarterly report for fiscal 2026
- Aktis Oncology, Inc. 10-Q 2025AKTS 10-Q 2025: quarterly report for fiscal 2025
- Aktis Oncology, Inc. 10-Q 2024AKTS 10-Q 2024: quarterly report for fiscal 2024
- Aktis Oncology, Inc. 10-Q 2023AKTS 10-Q 2023: quarterly report for fiscal 2023
- Aktis Oncology, Inc. 10-Q 2022AKTS 10-Q 2022: quarterly report for fiscal 2022
- Aktis Oncology, Inc. 8-K 2026AKTS 8-K 2026: current report for fiscal 2026
- Aktis Oncology, Inc. 8-K 2025AKTS 8-K 2025: current report for fiscal 2025
- Aktis Oncology, Inc. 8-K 2024AKTS 8-K 2024: current report for fiscal 2024
- Aktis Oncology, Inc. 8-K 2023AKTS 8-K 2023: current report for fiscal 2023
- Aktis Oncology, Inc. 8-K 2022AKTS 8-K 2022: current report for fiscal 2022
- Aktis Oncology, Inc. DEF 14A 2026AKTS DEF 14A 2026: proxy statement for fiscal 2026
- Aktis Oncology, Inc. DEF 14A 2025AKTS DEF 14A 2025: proxy statement for fiscal 2025
- Aktis Oncology, Inc. DEF 14A 2024AKTS DEF 14A 2024: proxy statement for fiscal 2024
- Aktis Oncology, Inc. DEF 14A 2023AKTS DEF 14A 2023: proxy statement for fiscal 2023
- Aktis Oncology, Inc. DEF 14A 2022AKTS DEF 14A 2022: proxy statement for fiscal 2022
- Aktis Oncology, Inc. Form 4 2026AKTS Form 4 2026: insider trading filing for fiscal 2026
- Aktis Oncology, Inc. Form 4 2025AKTS Form 4 2025: insider trading filing for fiscal 2025
- Aktis Oncology, Inc. Form 4 2024AKTS Form 4 2024: insider trading filing for fiscal 2024
- Aktis Oncology, Inc. Form 4 2023AKTS Form 4 2023: insider trading filing for fiscal 2023
- Aktis Oncology, Inc. Form 4 2022AKTS Form 4 2022: insider trading filing for fiscal 2022
- Aktis Oncology, Inc. S-1 2026AKTS S-1 2026: registration statement for fiscal 2026
- Aktis Oncology, Inc. S-1 2025AKTS S-1 2025: registration statement for fiscal 2025
- Aktis Oncology, Inc. S-1 2024AKTS S-1 2024: registration statement for fiscal 2024
- Aktis Oncology, Inc. S-1 2023AKTS S-1 2023: registration statement for fiscal 2023
- Aktis Oncology, Inc. S-1 2022AKTS S-1 2022: registration statement for fiscal 2022
- Aktis Oncology, Inc. 13F 2026AKTS 13F 2026: institutional holdings for fiscal 2026
- Aktis Oncology, Inc. 13F 2025AKTS 13F 2025: institutional holdings for fiscal 2025
- Aktis Oncology, Inc. 13F 2024AKTS 13F 2024: institutional holdings for fiscal 2024
- Aktis Oncology, Inc. 13F 2023AKTS 13F 2023: institutional holdings for fiscal 2023
- Aktis Oncology, Inc. 13F 2022AKTS 13F 2022: institutional holdings for fiscal 2022
More companies